We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

NewGenIvf Group Ltd (NIVF) NPV A

Sell:$0.54 Buy:$0.54 Change: $0.0518 (8.71%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$0.54
Buy:$0.54
Change: $0.0518 (8.71%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$0.54
Buy:$0.54
Change: $0.0518 (8.71%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NewGenIvf Group Ltd is a United States-based company. The Company is a assisted reproductive services (ARS) provider helping couples and individuals obtain access to fertility treatments. Its fertility treatments and providing two services: (i) in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and (ii) surrogacy and ancillary caring services. It specialized in the ARS market and the broader healthcare industry.

Contact details

Address:
Level 39, Marina Bay Financial Centre, T

018983
Singapore
Telephone:
+65 () 68185796
Website:
https://newgenivf.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NIVF
ISIN:
VGG0544E1051
Market cap:
$6.04 million
Shares in issue:
10.15 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
Virgin Islands
Currency:
US dollar
Indices:
n/a

Key personnel

  • Claudius Tsang
    Chairman of the Board, Chief Executive Officer, Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.